Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp)

Anticancer Research

Volumn 19, Issue 2 A, 1999, Pages 1053-1064

  Aszalos, Adorjan ^a   Thompson, Karol ^a   Yin, Jun Jie ^a   Ross, Douglas D ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Blockers; Mulidrug resistance associated protein; P glycoprotein

Indexed keywords

CELL MEMBRANE PROTEIN; CREMOPHOR; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; TRANSFER RNA; VALSPODAR; VERAPAMIL;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTIBODIES, MONOCLONAL; ATP-BINDING CASSETTE TRANSPORTERS; CELL DIVISION; CYCLOSPORINS; DRUG SYNERGISM; HUMANS; LEUKEMIA L1210; MEMBRANE POTENTIALS; MICE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; POLYETHYLENE GLYCOLS; VERAPAMIL;

EID: 0033053573     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV, Willingham MC: A retrovirus carrying MDR1 cDNA confers multiple drug resistance and polarized expression of P-glycoprotein in MDR cells. Proc Nat Acad Sci 85: 4486-4490, 1988.
2. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
3. Bowers VD, Loker S, Ames S, Jennings W, Corry RJ: The hemodynamic effect of Cremophor EL. Transplantation 51: 850-857, 1991.
4. Bohme M, Muller M, Leier I, Jedlitschky G, Kleppler D: Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 107: 255-265, 1994.
5. Salmon SA, Dalton WS, Grogan TM, Plezia P, Lehnert M, Toe DJ, Miller TP: Multidrug resistant myeloma: Laboratory and clinical effects of verapamil as a chemosensitizer. Blood 78: 44-50, 1991.
6. Hwang M, Ahn CH, Pine PS, Yin JJ, Hrycyna CA, Licht T, Aszalos A: Effect of combination of suboptimal concentrations of P-grycoprotein blockers on the proliferation of MDR1 gene expressing cells. Int J Cancer 65: 389-397, 1996.
7. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, Deeley RG: Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54: 5902-5910, 1994.
8. Leier I, Jedlitschky G, Buchholz U, Keppler D: Characterization of the ATP-dependent leukotriene C4 export carrier in mastocytoma cells. Eur J Biochem 220: 599-606, 1994.
9. Kruh GD, Gaughan T, Godwin A, Chan A: Expression pattern of MRP in human tissues and adult solid tumor cell lines. J Natl Cancer Inst 87: 1256-1258, 1995.
10. Currier SJ, Ueda K, Willingham MC, Pastan I Gottesman MM: Detection and insertion mutants of the multidrug transporter. J Biol Chem 264: 14376-14381, 1989.
11. Currier SJ, Kane SE, Willingham MC, Cardarelli CO, Pastan I, Gottesman MM: Identification of residues in the first cytoplasmic loop of P-glycoprotein linvolved in the function of Chimeric human MDR1-MDR2 transportes. J Biol Chem 267: 25153-25159, 1992.
12. Doyle LA, Ross DD, Ordonez IV, Yang W, Gao Y, Tong T, Belani CP, Gutheil JC: An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein. Br J Cancer 72: 535-541, 1995
13. Schneider E, Yamazaki H, Sinka BK, Cowan KH: Buthionine sulfoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involved increased drug accumulation. Br J Cancer 71: 738-744, 1995, 1995.
14. Aszalos A, Macy M, Sethi G, Luc V, Kalita C: Biological and physicochemical properties of some N-acyl daunorubicin derivatives. Biochem Pharmacol 28: 335-339, 1979.
15. Zaman GJR, Versantvoort CHM, Smit JJM, Eijdems EWHM, deHaas M. Smith AJ, Broxterman HJ, Mulder NH, de Vries EGE, Baas, Borst P: Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53: 1747-1750, 1993..
16. Balint B, Aszalos A, Grimley PM: Surface alterations of lymphoblast (Daudi) membranes exposed to interferon using fluorescence methods. In: Actual Problems in Luminescence Research. Vol 1, Spinger, Germany, 1991, p 166-171.
17. Weaver JL, Szabo G Jr, Pine PS, Gottesman MM, Goldenberg S, Aszalos A: The effect of ionchannel Blockers, immunosuppressive agents and other drugs on the activity of the multidrug transporter. Intl J Cancer 59: 456-461, 1993.
18. Weaver JL, Pine PS, Aszalos A, Schoenlein PV, Currier SJ, Padmanabhan R, Gottesman MM: Laser scanning and confocal microscopy of daunorubicin, doxorubicin and rhodamine 123 in multidrug-resistant cells. Exp Cell Res 196: 323-329, 1991.
19. Butterfield DA, Chesnut DA, Roses AD, Appel SH: Electron spin resonance studies of erythrocytes from patients with myotonic muscular dystrophy. Proc Nat Acad Sci 71: 909-913, 1974.
20. Webster L, Linsenmeyer M, Millward M, Morton C, Bishop J, Woodcock D: Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype. J Nat Cancer Inst 85: 1685-1690, 1993.
21. Lampidis TJ, Krishan A, Planas L, Tapiero H, Reversal of intrinsic resistance to adriamycin in normal cell by verapamil. Cancer Drug Deliv 3: 252-255, 1986.
22. Feller N, Kuiper CM, Lankelma J, Ruhdal JK, Scheper RJ, Pinedo HM, Broxterman HJ: Functional detection of MDRI/P170 and MRPIPI90-mediated multidrug resistance in tumor cells by flow cytometry. Br J Cancer 72: 543-549, 1995.
23. Lautier D, Canitrot Y, Deeley RG, Cole SPC: Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem Pharmacol 52: 967-977, 1996.
24. Versantvoort CHM, Rhodes T, Twentyman PR Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds. Br J Cancer 74: 1949-1954, 1996.
25. Castro AF, Altenberg GA: Inhibition of drug transport by genistein in mulidrug-resistant cells expressing P-glycoprotein. Biochem Pharmacol 53: 89-93, 1997.
26. Smith TC: The use of fluorescent dye to measure membrane potentials: a response. J Cell Physiol 112: 302-305, 1982.
27. Bakos E, Hegedus T, Hollo Zs, Welker E, Tusnady G.E, Zaman GJR, Flens MJ, Varadi A, Sarkadi B: Membrane topology and glycosylation of the human multidrug resistance-associated protein. J Biol Chem 271: 12322-12326, 1996.
28. Almquist KC, Loe DW, Hipfner DR, Mackie JE, Cole SPC, Deeley RG: Characterization of the 190 kDa multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res 55: 102-110, 1995..
29. Chan HSL, Lu Y, Grogan TM, Haddad G, Hipfner DR, Cole SPC, Deeley RG, Ling V, Gallie BL: Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporin for reversal of P-glycoprotein. Cancer Res 57: 2325-2330, 1997.